focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.75
Bid: 10.50
Ask: 11.00
Change: 1.00 (10.26%)
Spread: 0.50 (4.762%)
Open: 10.25
High: 10.75
Low: 10.25
Prev. Close: 9.75
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abingdon Health progresses at-home STD test programme

Mon, 25th Mar 2024 15:27

(Sharecast News) - Abingdon Health updated the market on the development of self-tests for sexually transmitted diseases (STDs) on Monday, announcing the completion of the 'design freeze' stage for four key tests in collaboration with Devyn.

The AIM-traded firm said the tests, covering HIV, hepatitis B, hepatitis C and syphilis, were developed under a CDMO contract with Devyn's subsidiary 'Find Out From Home'.

It said the development was part of a broader strategic partnership between Abingdon Health and Find Out, formalised through a service for equity agreement.

Under the agreement, Abingdon would continue to offer regulatory and technical transfer services, and also take a significant minority equity stake in Find Out.

As the exclusive manufacturer and regulatory partner for the products, Abingdon Health said it would lead distribution in the UK and Europe.

The initiative could tap into a growing demand for STD testing, with the global market expected to reach $145bn by 2035, driven by increasing STD cases among young adults and a lack of awareness about safe sex practices.

Abingdon said its chief executive officer Chris Yates would join the board of Find Out, further cementing the strategic alignment between the two entities.

"We are delighted to announce the strategic partnership with Find Out From Home," said chief executive officer Chris Yates.

"We have been working with the team at Find Out for the past year and are pleased that the initial set of four STD lateral flow tests have now reached design freeze."

Yates said the company was looking forward to deepening its partnership with Find Out, and ultimately launching the rapid STD tests into the European market.

"We believe there is a significant unmet need for accurate, user-friendly STD lateral flow tests and this partnership underlines our approach in supporting customers on bringing innovative lateral flow tests from "idea to commercial success."

At 1500 GMT, shares in Abingdon Health were up 8.11% at 10p.

Reporting by Josh White for Sharecast.com.

More News
23 Aug 2021 10:34

Abingdon Health shares rise on Covid-19 self-test launch

Abingdon Health shares rise on Covid-19 self-test launch

Read more
23 Aug 2021 07:43

Abingdon Health surges after launch of Covid-19 antibody self-test

(Sharecast News) - Abingdon Health surged on Monday after launching a Covid-19 antibody self-test it manufactured with BioSure.

Read more
12 Aug 2021 11:31

AIM WINNERS & LOSERS: Abingdon Health sinks as results disappoint

AIM WINNERS & LOSERS: Abingdon Health sinks as results disappoint

Read more
12 Aug 2021 10:58

Abingdon Health shares plummet on results at bottom end of guidance

Abingdon Health shares plummet on results at bottom end of guidance

Read more
12 Aug 2021 09:15

Abingdon Health FY revenues at bottom end of guidance

(Sharecast News) - Covid-19 test kit manufacturer Abingdon Health warned on Thursday that full-year revenues would be at the bottom end of forecasts.

Read more
23 Jul 2021 10:08

Abingdon Health inks manufacturing agreement for BioSure Covid tests

Abingdon Health inks manufacturing agreement for BioSure Covid tests

Read more
9 Jul 2021 21:41

TRADING UPDATES: JD Sports vows diversity, Sainsbury faces mini-revolt

TRADING UPDATES: JD Sports vows diversity, Sainsbury faces mini-revolt

Read more
5 Jul 2021 18:49

TRADING UPDATES: AVI wants Third Point change; ADVFN plans dividend

TRADING UPDATES: AVI wants Third Point change; ADVFN plans dividend

Read more
27 Apr 2021 10:32

Abingdon Health expects to report annual results below market forecast

Abingdon Health expects to report annual results below market forecast

Read more
27 Apr 2021 10:30

AIM WINNERS & LOSERS: Abingdon Health warns results to miss forecasts

AIM WINNERS & LOSERS: Abingdon Health warns results to miss forecasts

Read more
27 Apr 2021 09:54

Abingdon Health looks set to report FY underlying loss

(Sharecast News) - Abingdon Health warned on Tuesday that it looked set to post a full-year underlying loss despite stating it had continued to make progress on commercialising its AbC-19TM rapid test in the UK private sector and internationally.

Read more
10 Mar 2021 14:05

IN BRIEF: Abingdon Health signs distribution agreement with BioSure UK

IN BRIEF: Abingdon Health signs distribution agreement with BioSure UK

Read more
10 Mar 2021 09:27

Abingdon Health inks sales and distribution agreement with BioSure UK

(Sharecast News) - Rapid tests developer Abingdon Health has signed a non-exclusive sales and distribution agreement in the UK and Europe for its AbC-19 rapid neutralising antibody test with BioSure UK.

Read more
9 Mar 2021 17:07

TRADING UPDATES: Science Group swings to profit, eEnergy revenue grows

TRADING UPDATES: Science Group swings to profit, eEnergy revenue grows

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.